---
title: "Adaptive Biotechnologies Chief Commercial Officer Susan Bobulsky disposes of 5,000 shares for $115,000"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293262025.md"
description: "Adaptive Biotechnologies Chief Commercial Officer Susan Bobulsky sold 5,000 common shares on July 16, 2026, at $23 per share, totaling $115,000. Following the transaction, her direct holdings decreased to 401,288 shares. The information was published via EDGAR by Adaptive Biotechnologies Corporation."
datetime: "2026-07-20T23:20:30.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293262025.md)
  - [en](https://longbridge.com/en/news/293262025.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293262025.md)
---

# Adaptive Biotechnologies Chief Commercial Officer Susan Bobulsky disposes of 5,000 shares for $115,000

-   Adaptive Biotechnologies Chief Commercial Officer, MRD Susan Bobulsky sold 5,000 common shares on July 16, 2026 at USD 23. \* Direct holdings fell to 401,288 shares following the transaction. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Adaptive Biotechnologies Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001820885-26-000016), on July 20, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [ADPT.US](https://longbridge.com/en/quote/ADPT.US.md)

## Related News & Research

- [Adaptive Biotechnologies Chief Commercial Officer Susan Bobulsky disposes of 1,299 common shares for $31,176](https://longbridge.com/en/news/294743960.md)
- [Adaptive Biotechnologies CSO Harlan S. Robins reports disposal of common shares worth $10.77 million](https://longbridge.com/en/news/293677690.md)
- [Zalaris publishes minutes from extraordinary general meeting](https://longbridge.com/en/news/295536162.md)
- [Covivio announces availability of 2026 half-year report](https://longbridge.com/en/news/294781698.md)
- [Adaptive Biotechnologies CCO Susan Bobulsky sells 487 shares worth $10,714](https://longbridge.com/en/news/291851701.md)